Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone in Nondiabetics with Metabolic Syndrome
NCT00364221Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Nov 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in metabolic syndrome, sponsored by University of Colorado Denver. Started Nov 2004; status: completed.
02
Drugs
rosiglitazone
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00364221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364221.